Pediatric Research Alliance: Emory Children's GT

James Klosky, professor of pediatrics at Emory School of Medicine and director of psychology for the Aflac Cancer and Blood Disorders Center at Children’s Healthcare of Atlanta, and University of Alabama colleague Wendy Landier were awarded a $1.8 million U01 grant from the National Cancer Institute. The study will evaluate the effectiveness and implementation of an intervention to increase HPV vaccine uptake among young cancer survivors.

The National Academy of Medicine (NAM) has elected Denise J. Jamieson, MD, MPH, and Susan Margulies, PhD, to its prestigious 2020 class, consisting of 100 new members. Election to NAM is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. Read More: https://bit.ly/2UdcwP8

Emory University will enroll adult volunteers in a large-scale clinical trial designed to evaluate whether a single dose of an investigational vaccine can prevent symptomatic COVID-19. . The vaccine candidate, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, moved to Phase 3 trials after encouraging results from an earlier clinical study. . This is the first late stage trial to assess if a single dose vaccine can protect people against COVID-19.... Read More: https://bit.ly/3n67ccU See more

In severe cases of COVID-19, Emory researchers have been observing an exuberant activation of immune cells, resembling acute flares of systemic lupus erythematosus (SLE), an autoimmune disease. Their findings point towards tests that could separate some COVID-19 patients who need immune-calming therapies from others who may not. They also may begin to explain why some people infected with SARS-CoV-2 produce abundant antibodies against the virus, yet experience poor outcomes.

Children’s Healthcare of Atlanta, the Emory University School of Medicine and the Georgia Institute of Technology have received an additional $18.2 million from the National Institutes of Health (NIH) to continue their verification of COVID-19 diagnostic tests.